MEDICINE MAN TECH INC by Medicine Man Technologies Inc. Analyst Price Targets - Benzinga

SPY771.02+0.18%QQQ726.03−0.40%BTC/USD82,078.02+0.63%DIA520.96+1.03%GLD382.15+1.64%TLT80.14+1.58%

MEDICINE MAN TECH INC by Medicine Man Technologies Inc.

SHWZOTCEM

Trade with Public

Trade with Public

$0.000010

N/A

Last update: Sep 29, 12:00 PM

Overview News Earnings ForecastPrice TargetsFinancials Sentiment Ownership Compare

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

MEDICINE MAN TECH INC by Medicine Man Technologies Inc. Analyst Price Targets - Benzinga

MEDICINE MAN TECH INC by Medicine Man Technologies Inc. Analyst Price Targets

Wall Street analyst price targets and consensus rating for MEDICINE MAN TECH INC by Medicine Man Technologies Inc. (SHWZ).

Price Target Range — 3 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$3Upside to Avg. PT+24999900.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 14, 2024	Benchmark	Mike Hickey	Maintained	Buy	$3
May 16, 2024	Benchmark	Mike Hickey	Maintained	Buy	$3
Mar 28, 2024	Benchmark	Mike Hickey	PT Cut	Buy	$3→$3

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Benchmark Reiterates Buy on Medicine Man Technologies, Maintains $2.5 Price Target

Benchmark analyst Mike Hickey reiterates Medicine Man Technologies (OTC:SHWZ) with a Buy and maintains $2.5 price target.

Benzinga Newsdesk

Out Of Pocket: Which U.S. Cannabis Company Owes The Most Money In 2024?

In a recent report, Pablo Zuanic, senior analyst at Zuanic & Associates, analyzes the debt maturities of over 20 multi-state operators (MSOs) in the cannabis industry. This comprehensive review follows Ascend Wellness's significant $200 million debt refinancing.

Nicolás Jose Rodriguez

PRO
Benchmark Reiterates Buy on Medicine Man Technologies, Maintains $2.5 Price Target

Benchmark analyst Mike Hickey reiterates Medicine Man Technologies (OTC:SHWZ) with a Buy and maintains $2.5 price target.

Benzinga Newsdesk

Marijuana Investors Bet Big On Long-Term Growth Over Short-Term Earnings As Market Value Rises By 39%

Recent data from the Viridian Cannabis Deal Tracker highlights significant changes in the valuation multiples of major multi-state operators (MSOs) in the cannabis sector. The Viridian Cannabis Deal Tracker has become an indispensable tool for companies, investors and acquirers in the cannabis industry.

Nicolás Jose Rodriguez

Cannabis Market's Trading Volume Surges Up 292%, Viridian Capital Highlights Mixed Liquidity

A recent analysis by Viridian Capital Advisors provides intriguing insights into the liquidity of cannabis companies, indicating both advancements and setbacks in the sector.

Nicolás Jose Rodriguez

PRO
Benchmark Maintains Buy on Medicine Man Technologies, Lowers Price Target to $2.5

Benchmark analyst Mike Hickey maintains Medicine Man Technologies (OTC:SHWZ) with a Buy and lowers the price target from $3 to $2.5.

Benzinga Newsdesk